FFCP PHASE2:Hg19::chr14:33449543..33449553,-
From FANTOM5_SSTAR
Revision as of 20:13, 24 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr14:33449543..33449553, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr14:33449543..33449553, - |
Coexpression cluster: | C62_Burkitt_tonsil_CD19_submaxillary_spleen_salivary_lymph |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr14:33449543..33449553- |
---|
0
1
2
3
4
5
6
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 2.39e-66 | 1 |
mature B cell | 5.04e-34 | 2 |
pre-B-II cell | 5.04e-34 | 2 |
transitional stage B cell | 5.04e-34 | 2 |
small pre-B-II cell | 5.04e-34 | 2 |
immature B cell | 5.04e-34 | 2 |
lymphocyte of B lineage | 1.16e-25 | 24 |
pro-B cell | 1.16e-25 | 24 |
precursor B cell | 3.27e-23 | 3 |
lymphoid lineage restricted progenitor cell | 1.77e-12 | 52 |
Showing 1 to 10 of 12 entries
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 2.39e-66 | 1 |
lymphosarcoma | 2.39e-66 | 1 |
lymphoma | 1.10e-59 | 10 |
hematologic cancer | 1.06e-12 | 51 |
immune system cancer | 1.06e-12 | 51 |
Showing 1 to 5 of 5 entries